XML 81 R57.htm IDEA: XBRL DOCUMENT
v3.25.1

DRL Development Agreement - Additional Information (Details) - USD ($) | 1 Months Ended | 12 Months Ended |
--- | --- | --- | ---
Jun. 30, 2024 | Dec. 31, 2023 | Dec. 31, 2024 | Dec. 31, 2023 | Jan. 31, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |
Transaction price allocated to performance obligation, revenue recognized |  |  | $ 484,810 | $ 23,146 |
Deferred Revenue, Current, Total |  | $ 923,109 | 848,286 | 923,109 |
Deferred collaboration revenue |  | 574,685 | 945,447 | 574,685 |
DRL Development Agreement |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |
Upfront nonrefundable payment receivable |  |  | 7,500,000 |  | $ 7,500,000
Transaction price allocated to performance obligation, revenue recognized |  |  |  | $ 6,000,000 |
Deferred Revenue, Current, Total |  |  | 900,000 |  |
Deferred collaboration revenue |  |  | 1,800,000 |  |
Collaboration revenue |  |  | 300,000 |  |
DRL Development Agreement | First Amendment |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |
One-time payment | $ 3,900,000 |  |  |  |
Royalty payments | 6,000,000 |  |  |  |
Transaction price | $ 3,900,000 |  |  |  |
DRL Development Agreement | Maximum |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |
Developmental milestones |  | 40,000,000 |  |  |
Sales milestones |  | 677,300,000 |  |  |
DRL Development Agreement | Treatment for ALS |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |
Additional Payment entitled to receive |  | 4,200,000 |  |  |
Addtional payment receivable upon dosing of the first patient |  | $ 4,200,000 |  |  |
DRL Development Agreement | R&D Services |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |
Transaction price allocated to performance obligation |  |  | 1,500,000 |  |
DRL Development Agreement | R&D Services | First Amendment |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |
Transaction price |  |  | 500,000 |  |
DRL Development Agreement | License | First Amendment |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |
Transaction price |  |  | $ 3,100,000 |  |

X
- Definition Achievement of developmental milestones + References No definition available. + Details
Name: | coya_AchievementOfDevelopmentalMilestones
Namespace Prefix: | coya_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Achievement of sales milestones. + References No definition available. + Details
Name: | coya_AchievementOfSalesMilestones
Namespace Prefix: | coya_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Additional payment receivable upon FDA acceptance of investigational new drug. + References No definition available. + Details
Name: | coya_AdditionalPaymentReceivableUponFDAAcceptanceOfInvestigationalNewDrug
Namespace Prefix: | coya_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Addtional payment receivable upon dosing of the first patient. + References No definition available. + Details
Name: | coya_AddtionalPaymentReceivableUponDosingOfTheFirstPatient
Namespace Prefix: | coya_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Collaboration revenue. + References No definition available. + Details
Name: | coya_CollaborationRevenue
Namespace Prefix: | coya_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Deferred collaboration revenue. + References No definition available. + Details
Name: | coya_DeferredCollaborationRevenue
Namespace Prefix: | coya_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Drl development agreement one time payment. + References No definition available. + Details
Name: | coya_DrlDevelopmentAgreementOneTimePayment
Namespace Prefix: | coya_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Drl development agreement royalty payments. + References No definition available. + Details
Name: | coya_DrlDevelopmentAgreementRoyaltyPayments
Namespace Prefix: | coya_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Drl development agreement transaction price. + References No definition available. + Details
Name: | coya_DrlDevelopmentAgreementTransactionPrice
Namespace Prefix: | coya_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Upfront nonrefundable payment receivable. + References No definition available. + Details
Name: | coya_UpfrontNonrefundablePaymentReceivable
Namespace Prefix: | coya_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8 + Details
Name: | us-gaap_ContractWithCustomerLiabilityRevenueRecognized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(20)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_DeferredRevenueCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of transaction price allocated to performance obligation that has not been recognized as revenue. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (a) -SubTopic 10 -Topic 606 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13 + Details
Name: | us-gaap_RevenueRemainingPerformanceObligation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=coya_DrlDevelopmentAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CumulativeEffectPeriodOfAdoptionAxis=coya_FirstAmendmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=coya_TreatmentForALSMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=coya_ResearchAndDevelopmentServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=us-gaap_LicenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |